Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:23 pm Sale |
2021-12-31 | 13G | Cue Biopharma, Inc. CUE |
Corriente Advisors LLC | 0 0.000% |
-1,915,219 (Position Closed) |
Filing History |
| 2022-02-14 4:10 pm Sale |
2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Corriente Advisors LLC | 0 0.000% |
-54,000 (Position Closed) |
Filing History |
| 2022-02-14 4:04 pm Sale |
2021-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Corriente Advisors LLC | 0 0.000% |
-2,000,000 (Position Closed) |
Filing History |
| 2021-02-16 06:33 am Purchase |
2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP |
Corriente Advisors LLC | 54,000 6.070% |
54,000 (New Position) |
Filing History |
| 2021-02-16 06:28 am Purchase |
2020-12-31 | 13G | Cue Biopharma, Inc. CUE |
Corriente Advisors LLC | 1,915,219 6.330% |
1,915,219 (New Position) |
Filing History |
| 2021-02-16 06:26 am Sale |
2020-12-31 | 13G | Astria Therapeutics, Inc. ATXS |
Corriente Advisors LLC | 0 0.000% |
-134,097 (Position Closed) |
Filing History |
| 2021-02-16 06:23 am Sale |
2020-12-31 | 13G | BowFlex Inc. BFXXQ |
Corriente Advisors LLC | 0 0.000% |
-1,813,822 (Position Closed) |
Filing History |
| 2021-02-16 06:18 am Purchase |
2020-12-31 | 13G | Cardiff Oncology, Inc. CRDF |
Corriente Advisors LLC | 2,000,000 5.660% |
2,000,000 (New Position) |
Filing History |